Business News:

Do you have a press release about your business? There is no need for you to pay us for posting your press release - you can post for free right now. More »

International News:

You can even break international news here as well. More »

Hobby News:

Have a passion for motorcycles? Post your release about your motorcycle club here and get more eyes and clicks to your website. More »

Sign up today!

Before you can do anything you need to sign up! More »

Post your press release here

Post your press release here and promote your resource More »



Press Release :- New Delhi, India :- Image Sensor India is the channel partner with ON semiconductor, USA & actively supplying Image sensors to our valued OEM customer’s.We holds large portfolio of CMOS Image sensor from ON Semiconductor, USA. The Image Sensors comes with below features: below features:

– Industrial Imaging and Inspection
– Security, Surveillance, and Intelligent Traffic Systems
– Medical Imaging.

Image Sensor India holds strong expertise in OEM/custom camera design & development. Projects may include developing complete machine vision solution, or portion of it. BalaJi MicroTechnologies (BMT) leverages its unique experience and expertise built over the years to offer research and development services to solve complex image processing problems and build innovative  machine vision  based solutions for OEM applications.

Image Sensor India owned & maintained by BalaJi MicroTechnologies (BMT), India.

Please Visit Product page :-

Sales Contact:-

Office Tel:- +91-129-4006203, +91-129-6561300
Office Mobile:- +919643047670
Skype ID(For Product Inquiry): bmt.overseas
Whatsapp(For Product Inquiry): +919643047670
Email (product inquiry):-

Image Sensor, Full Frame Image Sensor, Linear Image Sensor, CCD Image Sensor, CMOS Image Sensor, EMCCD Image Sensor.

Share Button


Press Release :- New Delhi, India :- Image Sensor India is the channel partner with ON semiconductor, USA & actively supplying Image sensors to our valued OEM customer’s.We holds large portfolio of CCD Image sensor’s from ON Semiconductor, USA. The Image Sensors comes with below features:

– Resolutions from 1 to 29 megapixels
– “Plug and Play” sensors allow a single camera design to support the entire product family
– Device ID pin lets camera identify the specific sensor plugged into camera board
– Common pixel design provides outstanding imaging performance across product portfolio
– Bayer Color Pattern, TRUESENSE Sparse Color Filter Pattern, and Monochrome configurations

1920 (H) x 1080 (V) Interline Transfer EMCCD IMAGE SENSOR

The KAE-02150 Image Sensor is a 1080p (1920 × 1080) CCD in a 2/3? optical format that provides exceptional imaging performance in extreme low light applications. Each of the sensor’s four outputs incorporate both a conventional horizontal CCD register and a high gain EMCCD register. An intra-scene switchable gain feature samples each charge packet on a pixel-by-pixel basis. This enables the camera system to determine whether the charge will be routed through the normal gain output or the EMCCD output based on a user selectable threshold. This feature enables imaging in extreme low light, even when bright objects are within a dark scene, allowing a single camera to capture quality images from sunlight to starlight.

Image Sensor India owned & maintained by BalaJi MicroTechnologies (BMT), India.

Please Visit Product page :-

Sales Contact:-

Office Tel:- +91-129-4006203, +91-129-6561300
Office Mobile:- +919643047670
Skype ID(For Product Inquiry): bmt.overseas
Whatsapp(For Product Inquiry): +919643047670
Email (product inquiry):-

Image Sensor, Full Frame Image Sensor, Linear Image Sensor, CCD Image Sensor, CMOS Image Sensor, EMCCD Image Sensor.

Share Button

Mobile Content Management Market, 2017-2027 by Segmentation: Based on Product, Application and Region

There is tremendous increase in the number of employees accessing the content of the organization through the mobile devices thereby forcing the organizations to convert electronic access of all enterprise content compatible with mobile devices in order to ensure secure access. The mobile content management market is expected to grow as the growth in the information management industry and widespread use of smartphones, tablets impact the way content management is done in organizations. Employees accessing content through mobile phone has been increased drastically there by forcing industries to convert from just firewall protection for internet access to that one provide secure access through an intuitive interface from any device and any location.

Organizations adopt mobile content management solution if they are intuitive and easy to use and should have features and functionalities that provides users a clear business view.

The mobile content management solutions market is growing as many organizations are implementing BYOD where user can access content from any device. Many mobile content management Companies offering BYOD solutions through a standalone app or workspace solution which support access across all operating systems.

The major advantages offered for the organizations by the implementation of mobile content management solutions include flexible storage, enterprise graded security and easy with which a file can be shared.

Request For Report Sample@

Mobile Content Management Market: Drivers and Challenges

The major driver for Global Mobile Content Management Market is increase in access of enterprise content from the mobile device by the employers and also due to implementation of BYOD by many organizations so that content can be accessed from any device.

Security of corporate data is of primarily concern for the organizations as content access through mobile device should be encrypted for avoiding cyber threats which can be done by deploying mobile content management solutions which is biggest driving force for the mobile content management market.

The major challenges to be considered by the mobile content management solution providers is the application should be user friendly, and should be easily deployed along with it the data usage costs must be low with adoption to different mobile operating systems.

Mobile Content Management Market: Segmentation

Mobile content management market can be segmented on the basis of type of deployment, size of organizations, vertical and region

On the basis of type of deployment, mobile content management market can be segmented into cloud based and on-premise.

On the basis of size of organization, mobile content management market can be segmented into small and medium enterprises (SMEs) and large enterprises

On the basis of vertical, mobile content management market can be segmented into media and entertainment sector, BFSI, healthcare sector, transportation, public sector, manufacturing sector, retail sector, IT & Telecom sector, energy & utilities and others

Request For TOC@

Mobile Content Management Market: Regional Overview

Regionally, mobile content management market can be segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East and Africa

Majority of the mobile content management market is shared by North America region as large number organizations are deploying the mobile content management platform in order compete in the dynamic environment. North America region is followed by Europe Region. European region is expected to have a high rate during the forecast period. Asia Pacific region is also expected to have significant growth during the forecast period.

Mobile Content Management Market: Competition Landscape

Few prominent players in the Mobile Content Management Market include:Alfresco Software Inc., Colligo Networks Inc., Mobileiron, CA Technologies, XAIT, Citrix Systems Inc., VMware Inc. (Air-Watch), and SOTI Inc.

Browse Full Report@

Share Button

Antinuclear Antibody Test Market: Technological Advancements, Trends and Insights 2016 – 2024

Antinuclear antibody test is a sensitive screening test used to diagnose autoimmune disorders. The test is used in symptoms such as low-grade fever, skin sensitivity to light, persistent fatigue, weakness and inflammation, and damage to organs and tissues. The test gives two types of results: positive result and negative result.

A positive test indicates the presence of autoantibody. Enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody (IFA) are the two types of tests commonly performed to detect antinuclear antibody test. ELISA test results are reported as arbitrary units, and IFA test results are reported as rations, for example 1:320, which indicates one part of blood sample was mixed with 320 parts of a diluting substance. About 95% of antinuclear test is used to test lupus autoimmune disease. Lupus disease is followed by scleroderma (systemic sclerosis) and Sjögren’s syndrome which shows positive results in about 60% and 40% cases, respectively.

The prevalence of antinuclear antibody in healthy individuals is about 3% to 15% and production of autoantibody is age dependent, which increases from 10% to 37% over age 65. The antinuclear antibody test further provides additional diagnostic and prognostic information about the nature of the autoimmune process based on the targeted antigens. Other therapeutic conditions with modest frequency of antinuclear antibody are thyroid, rheumatoid arthritis, HIV, and hepatitis C.

Factors such as growth in health care awareness among people and increase in prevalence of autoimmune diseases, such as rheumatoid arthritis and type I diabetes, are driving the global antinuclear antibody test market. According to WHO, the number of people suffering from diabetes has increased from 108 million in 1980 to 422 million in 2014, and it is expected to increase further in the near future. Other factors such as government health care insurance & reimbursement policies and increase in health care expenditure are projected to fuel the antinuclear antibody test market. However, factors such as stringent regulation for product approval, diagnostic errors, and unavailability of skilled labor are estimated to hinder the antinuclear antibody test market globally.

The antinuclear antibody test reagents market has been segmented by test type, product type, end-user, and geography. In terms of test type, the antinuclear antibody test market is classified into ELISA, IFA, and Dot Blot test. In terms of product type, the market is classified into assay kits and reagents. In terms of end-user, the antinuclear antibody test market is classified into hospitals, clinics, diagnostic centers, and research laboratories. The hospitals segment is expected to contribute a significantly large share due to developed infrastructure and safety test procedure. Geographically, the market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Geographically, North America dominates the market owing to early disease diagnosis, growth in number of autoimmune diseases such as lupus, developed health care infrastructure, and large number of geriatric population. These factors are estimated to drive the antinuclear antibody test market in the region. According to Lupus Foundation of America, 1.5 million Americans and approximately 5 million people are living with lupus disease.

Make an Enquiry @

North America is followed by Europe with a large market for antinuclear antibody test. Asia Pacific is expected to grow at a higher rate during the forecast period due to rapid rise in population, high prevalence of autoimmune disorders, increase in public awareness, and improvement in health care infrastructure, which in turn boost the antinuclear antibody test market. Growing number of government awareness campaigns is the driving factor boosting patients to seek clinical diagnostics even for disease symptoms. Other emerging countries such as Brazil and South Africa are anticipated to create a large opportunity for the antinuclear antibody test market.

Major players operating in this market include Alere Inc., Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Bio-Rad Laboratories, Inc., Becton Dickinson and Company, Biocom Biotech, Erba Diagnostics, ZEUS Scientific, Inc., and F. Hoffmann-La Roche Ltd.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Share Button

Ophthalmic Lasers Market Development Status and Outlook 2024

Ophthalmic lasers find applications in the treatment of various ophthalmic diseases that cause blindness, such as glaucoma, cataract, diabetic retinopathy, and age related macular degeneration (AMD), among others. Various types of lasers are employed for the treatment of these diseases, including diode lasers, Nd:YAG lasers, argon lasers and SLT, among others.

Obtain Report Details @

As per a new research study by Transparency Market Research (TMR), the global ophthalmic lasers market demonstrates a moderately competitive landscape and is led by Alcon, Carl Zeiss, Lumenis Ltd., Ellex Medical Laser Ltd., and Quantel Group. These players, however, hold only a marginal share of this market. In 2015, they collectively accounted for a share of nearly 35% in the overall market.

Over the forthcoming years, the market is likely to experience intense competition due to the entry of large pharmaceutical drugmakers into the market for surgical devices through strategic acquisitions.

According to the research report, the opportunity in the global market for ophthalmic lasers was worth US$0.97 bn in 2015. Rising at a CAGR of 4.60% during the period from 2016 to 2024, the market is likely to increase to US$1.44 bn by the end of the forecast period. Ophthalmic clinics have surfaced as the key end users of ophthalmic lasers across the world and are likely to remain so over the coming years.

North America to Retain Leadership as Asia Pacific Offers Lucrative Opportunities

In terms of geographies, the research report classifies the worldwide market for ophthalmic lasers is classified into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa. In 2016, North America led this market with a share of more than 40%, where the presence of a large pool of established players played the central role.

Over the next few years, with the help of the increasing research and development activities, availability of a well-established regulatory framework for the timely approval of the products, and the presence of a state-of-art healthcare infrastructure, the North America market for ophthalmic lasers is anticipated to continue its leading streak. Asia Pacific, on the other hand, is projected to surface as the most lucrative market for ophthalmic lasers across the world in the near future. China is expected to lead the Asia Pacific market for ophthalmic lasers in the years to come.

The Middle East and Africa and Latin America are also expected to register steady growth in their respective markets for ophthalmic lasers over the forthcoming years, thanks to the remarkable rise in medical tourism and the cost efficiency of laser eye surgeries in these regions. The Latin America market for ophthalmic lasers is projected to be led by Mexico and Columbia while Turkey will emerge as the key domestic market in the Middle East and Africa over the coming years, states the research report.

Rising Awareness Pertaining to Ophthalmic Lasers to Fuel Demand

“The increasing prevalence of vision impairment has the most significant influence on demand for ophthalmic laser surgeries,” states a TMR analysts. The incidence of partial as well as complete blindness across the world has been augmenting substantially and is projected to double up by 2020. Cataract, glaucoma, and diabetic retinopathy are the prime cause of blindness in humans and timely medical intervention can avoid these conditions. As ophthalmic laser surgeries provide effective treatment for these conditions, their popularity is rising substantially with the growing awareness about these surgeries among consumers, reflecting greatly on their demand.

For more information on this report, fill the form @

In addition to this, the technological advancements in ophthalmic lasers are likely to propel this market substantially over the next few years. However, the absence of an appropriate reimbursement scenario in many economies, specifically the emerging ones, may hamper the growth of this market.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

Share Button